Capricor Therapeutics (CAPR) Asset Utilization Ratio (2012 - 2025)

Capricor Therapeutics' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.09 for Q3 2025.

• In Q3 2025, Asset Utilization Ratio fell 80.16% year-over-year to 0.09; the TTM figure through Sep 2025 stood at 0.09 (down 80.16% YoY), while the FY2024 annual figure was 0.19, down 58.0% from the prior year.
• Asset Utilization Ratio was 0.09 for Q3 2025 at Capricor Therapeutics, down from 0.09 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.74 in Q2 2024 to a low of 0.0 in Q1 2021.
• Historically, Asset Utilization Ratio has averaged 0.21 across 5 years, with a median of 0.11 in 2023.
• The sharpest annual moves came in 2021 and 2023: Asset Utilization Ratio tumbled 94.4% in 2021, then surged 970.54% in 2023.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then jumped by 745.62% to 0.05 in 2022, then soared by 970.54% to 0.53 in 2023, then tumbled by 60.44% to 0.21 in 2024, then slumped by 58.79% to 0.09 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.09 (Q3 2025), 0.09 (Q2 2025), and 0.11 (Q1 2025), per Business Quant data.